The Hospital Acquired Pneumonia Prevention Market is segmented by Type (Oral Care Kit, Toothbrush, Swab, Moisturizer, Mouth Wash, Suction Tools), End-Use (Hospitals, Rehabilitation Centers, Home Care Settings), and Region (North America, Europe, Asia-Pacific, and Rest of the World).
The Hospital Acquired Pneumonia Prevention Market is segmented by Type (Oral Care Kit, Toothbrush, Swab, Moisturizer, Mouth Wash, Suction Tools), End-Use (Hospitals, Rehabilitation Centers, Home Care Settings), and Region ...
With an expanding geriatric population across the globe, the immunity level is observed to fall significantly. These two factors are expected to collectively propel the need for hospital-acquired pneumonia prevention in the next few years. Moreover, the rising prevalence of chronic diseases along with lengthy hospital stay duration will also escalate the chances of acquiring infections such as pneumonia, eventually pushing the demand for the prevention of hospital-acquired pneumonia, thus bolstering industry growth.
COVID-19 Impact
The COVID-19 outbreak positively influenced the hospital-acquired pneumonia prevention market growth. The pandemic resulted in a soaring number of affected patients across the globe, which put a strain on the healthcare sector. To prevent the spread of infection, there was a strong need for hospital-acquired pneumonia prevention amid the pandemic.
What is hospital-acquired pneumonia?
Hospital Acquired Pneumonia (HAP) is defined as a lower respiratory infection that does not incubate at the time of hospital admission but presents clinically for two or more days after hospitalization. Incidence of HAP is highly prevalent in the medical and surgical Intensive Care Units, and results in an additional cost to the healthcare centers and increases the length of stay in ICU.
Key Players
Key players operating in the hospital-acquired pneumonia prevention market are-
Halyard Health, Inc. (US)
Intersurgical Ltd. (UK)
Medline Industries, Inc. (US)
Sage Products LLC (Stryker Corporation) (US).
Segment Analysis
End-Use Trends
By end-use, the hospital-acquired pneumonia prevention market has been classified into hospitals, rehabilitation centers, and home care settings. Under these, the hospital's segment accounted for a significant market share in 2020 and is projected to register significant growth during the review period. Several patients who remain hospitalized for a long duration are suffering from pneumonia. Hence, the risk of acquiring pneumonia for a healthy person is much greater across hospitals and healthcare centers, which fosters segment growth.
Regional Analysis
The market in North America accounted for the largest market share in 2020 and is projected to grow at a significant CAGR during the assessment period. This is mainly ascribed presence of a large number of hospitals, stringent sterilization, and sanitary activities in the region, the presence of well-established healthcare infrastructure, and advancements in the field of hospital hygiene and care, which further proliferates the regional market growth.
Here is the list of the group of customers that the market hopes to have the greatest opportunity to convert-
Distributors
Suppliers
Manufacturers
Logistics organizations
Government bodies
Report Features
This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market.
What deliverables will you get in this report?
Key questions this report answers
Relevant contents in the report
How big is the sales opportunity?
In-depth analysis of the Hospital Acquired Pneumonia Prevention Market
How lucrative is the future?
Market forecast and trend data and emerging trends
Which regions offer the best sales opportunities?
Global, regional and country level historical data and forecasts
Which are the most attractive market segments?
Market segment analysis and forecast
Which are the top players and their market positioning?
Porter’s five forces analysis, PEST analysis, Life cycle analysis
What are the factors affecting the market?
Drivers & challenges
Will I get the information on my specific requirement?
10% free customization
Research Methodology
This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles, have been leveraged to gather the data. We conducted more than 15 detailed primary interviews with the market players across the value chain in all four regions and industry experts to obtain both qualitative and quantitative insights.
Customization Options
With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:
Company Profiling
Detailed profiling of additional market players (up to three players)
SWOT analysis of key players (up to three players)
Competitive Benchmarking
Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances.
Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com.
LOADING
LOADING
×
Please enter your contact details. It will allow our analysts to reach out to you.
Halyard Health, Inc. (US), Intersurgical Ltd. (UK), Medline Industries, Inc. (US), and Sage Prod-ucts LLC (Stryker Corporation) (US) are among the key players in the hospital-acquired pneumonia prevention market.
Expanding geriatric population across the globe, the rising prevalence of chronic diseases along with lengthy hospital stay duration are the factors driving the growth of hospital-acquired pneumonia prevention market.